Compare Figure Technology Solutions Inc. Class A Common Stock (FIGR) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figure Technology Solutions Inc. Class A Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Figure Technology Solutions Inc. Class A Common Stock trades at $28.68 (market cap $6.19B), while ImmunityBio Inc. Common Stock trades at $10.53 (market cap $10.51B). The key difference: ImmunityBio Inc. Common Stock is the larger of the two by market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, Figure Technology Solutions Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Figure Technology Solutions Inc. Class A Common Stock for 1 Days and ImmunityBio Inc. Common Stock for 1 Days on average.
| FIGR | IBRX | |
|---|---|---|
Market Cap | $6.19B | $10.51B |
Volume | 4,762,342 | 10,445,785 |
Sector | Financials | Health |
52-Week High | $73.91 | $11.55 |
52-Week Low | $24.91 | $1.98 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $6.23B | $10.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Figure Technology Solutions Inc. Class A Common Stock
Figure Technology Solutions operates a blockchain-native capital marketplace. Its platform supports loan origination, funding, sale, and trading of tokenized assets, along with digital-asset infrastructure and services.
Read more on FIGR →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
